AllSight
Companies · SMG · Agricultural Chemicals · Material agreement · Aug 27, 2026

Scotts Miracle-Gro amends receivables facility with no new funding terms disclosed

Receivables facility amendedpriced in
Third amendment to the master receivables purchase agreement; facility remains uncommitted
SCOTTS MIRACLE-GRO CO (SMG) — what happened, in plain English, and what it means versus what the market expected.

This is a financing-document update, not a new capital raise. Scotts amended its master receivables purchase agreement with JPMorgan Chase, but the filing does not disclose a new facility size, pricing change, maturity extension, or additional borrowing capacity. The agreement remains an “uncommitted” receivables purchase facility. 〔0〕

The filing provides no clear beat-or-miss signal against expectations. It contains no operating results, guidance, transaction value, or other financial metric to compare with consensus. Instead, it says the existing RPA provisions remain in force except for the specific amendments. 〔1〕

Net read: neutral and routine. The amendment may matter operationally, but the supplied filing does not identify what changed economically, so there is no substantiated basis to call it positive or negative versus the market’s standing expectation.

Read the original 8-K on SEC EDGAR ↗
All SMG filings, decoded →
Related companies in Agricultural Chemicals
Latest across the market
BBYBest Buy beats Q2 expectations as domestic demand surges and guidance risesCORZCore Scientific adds $600M bank facility, but only $100M is cash liquidityMBUUMalibu Boats beats Q4 estimates as Saxdor lifts sales, but FY26 margins slidePURRHyperliquid Strategies posts $305.5M profit as HYPE holdings surge, but gains are mostly paperMBXMBX Biosciences starts canvuparatide Phase 3 on schedule, with efficacy still unprovenKRMNKarman names new CFO after IPO, but incumbent’s departure adds transition riskBrowse all companies, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.